Everything below concerns cold chain. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-10-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Reconstituted solutions are less stable than the dry powder, and stability depends on concentration, pH, buffer composition, and container material. Low-protein-binding tubes reduce loss of peptide to plastic surfaces. Some researchers add a carrier protein to limit adsorption at low concentrations. The exact shelf life of a given solution is best determined empirically through a stability study rather than assumed from general guidance, because published data cover only a limited set of conditions.
Storage conditions for semaglutide depend heavily on the presentation. Lyophilized research powder is generally kept at two to eight degrees Celsius in a sealed container, protected from light and moisture. Manufacturer labeling for finished injectable products specifies refrigeration before first use, with defined in-use periods at room temperature afterward. The oral tablet form is stored at controlled room temperature and is more tolerant of short excursions. Temperature excursions should be documented rather than inferred.
Peptide degradation follows several routes. Hydrolysis cleaves the backbone at susceptible residues, oxidation targets methionine and tryptophan side chains, and aggregation produces higher-molecular-weight species that are difficult to reverse. Light exposure accelerates oxidation, which is why amber glass or opaque secondary packaging is common. Repeated freeze-thaw cycles promote aggregation and are best avoided. Stability-indicating methods detect these changes before they become visible.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
The compound binds the GLP-1 receptor on pancreatic beta cells and other tissues, activating a G-protein signaling cascade that raises intracellular cyclic AMP. This action increases glucose-dependent insulin secretion when blood glucose is elevated, while binding also slows gastric emptying and reduces glucagon release. In the central nervous system, receptor activation in the hypothalamus and brainstem contributes to reduced appetite. The fatty acid chain binds albumin, which protects the peptide from renal filtration and enzymatic degradation. This albumin binding is central to its extended circulation time.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
| Property | Value | Notes |
|---|---|---|
| Purity specification (research grade) | Greater than 95 percent by HPLC | Area percent at 220 nm; method dependent |
| Identity confirmation | Mass spectrometry | Observed mass compared with theoretical |
| Residual water | Reported by Karl Fischer titration | Affects peptide content calculation |
| Common synonyms | GLP-1 analog; GLP-1 receptor agonist peptide | Naming varies across catalogs |
| Container material | Low-binding polypropylene | Reduces adsorption at low concentration |
肽类的主要降解路径包括天冬酰胺脱酰胺、甲硫氨酸氧化、天冬氨酸异构化以及由 β-折叠驱动的聚集，这些反应对 pH 与缓冲液种类较为敏感。磷酸盐、丙二醇与苯酚等辅料会影响局部微环境与界面行为。强制降解研究借助高温、强光、氧化剂与极端 pH 暴露来预测产物谱。关于长期室温存放的数据相对有限，超出标签条件的稳定性仍属开放问题，需要在具体制剂中通过实时与加速试验加以确认。
容器与密封系统同样参与稳定性表现。硅油涂层、胶塞材质与顶空氧含量可能改变聚集速率与氧化水平。分析结果因此需要在完整包装形式下评估，而不能仅凭原料药数据推断。法规文件通常要求同时提交批次数据与代表性容器中的稳定性趋势。
关于降解产物的免疫原性风险，文献中仍有讨论空间。体外聚集水平与临床免疫反应之间的定量关系尚未确立。多数公开研究只报告理化指标，缺少长期随访的对应数据。这一问题在生物类似物比对中尤其受到关注。
Lyophilised semaglutide is generally held at -20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept at 2-8 °C and used within a defined window because degradation accumulates over time. Repeated freeze-thaw cycles are discouraged, since each cycle can promote aggregation and reduce monomeric content. Room-temperature stability of the solid has been examined in some studies but remains incompletely characterised for long durations, so cold storage is the conservative default for research material.
Degradation proceeds along several parallel routes. Deamidation of asparagine and glutamine residues generates charged variants that shift retention time in chromatographic analysis. Oxidation targets methionine and can be accelerated by trace metals or dissolved oxygen. Non-covalent aggregation produces dimers, oligomers, and larger species that are difficult to reverse. Isomerisation at aspartate residues is slower but measurable under thermal stress. The distribution among these pathways depends on pH, buffer composition, ionic strength, and the presence of excipients such as sugars or surfactants.
As a peptide, semaglutide is sensitive to conditions that break amide bonds or modify side chains. Deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation are the main degradation routes described in published stability work. Rate depends strongly on pH, buffer species, ionic strength, temperature and exposure to light. Formulators therefore choose a defined solution pH and often add excipients such as phosphate buffer, propylene glycol and phenol, each of which plays a separate role in pH control, tonicity or preservation.
Storage guidance for the finished injectable product distinguishes the unused state from the in-use state. Before first use, pens are kept refrigerated between 2 and 8 degrees Celsius, protected from light, and never frozen, since freezing can disrupt the peptide or the device. After first use, label instructions in several markets permit storage at room temperature up to about 30 degrees Celsius for a limited number of days. Solid research-grade material is normally held at or below minus 20 degrees Celsius, often with desiccant, and allowed to equilibrate before opening.
On 2 February, she met in Miraflores Palace with Delcy and Jorge Rodríguez to establish "the work agenda between the Bolivarian Republic of Venezuela and the United States." After the meeting, the US embassy shared on social media that Dogu met with the Venezuelan administration to "reiterate the three phases that US Secretary of State Marco Rubio had outlined for Venezuela: stabilization, economic recovery and reconciliation, and transition." Felix Plasencia was named as diplomatic representative of Venezuela to the United States. United States Energy Secretary Chris Wright arrived to Caracas on 11 February to make an assessment on Venezuela's oil industry. He met with Delcy Rodríguez in the presidential palace. Days before, Wright said he was expecting to "visit some of the nation's oil fields to see firsthand how President Trump's historic US-Venezuela Energy Deal is unleashing peace and prosperity." According to the Venezuelan information minister, they discussed a bilateral energy agenda. The last US Energy Secretary that visited Venezuela before that was Bill Richardson in 2001 under US president Bill Clinton. Dogu and Plasencia received a US shipment of six metric tons of medicine and medical supplies that arrived in Venezuela on 13 February. Dogu indicated it was "the first of many donations" that will arrive "in the coming days". Plasencia said that it was a "message of cooperation among two sovereign countries." When asked by reporters on 13 February, Trump said that he was "going to make a visit to Venezuela" but did not provide more details.
Mass spectrometry (MS) represents one of the main technologies for quantitative proteomics with advantages and disadvantages. Quantitative MS has higher sensitivity but can provide only limited information about the intact protein. Quantitative MS has been used for both discovery and targeted proteomic analysis to understand global proteomic dynamics in populations of cells (bulk analysis) or in individual cells (single-cell analysis). Early approaches developed in the 1990s applied isotope-coded affinity tags (ICAT), which uses two reagents with heavy and light isotopes, respectively, and a biotin affinity tag to modify cysteine containing peptides. This technology has been used to label whole Saccharomyces cerevisiae cells, and, in conjunction with mass spectrometry, helped lay the foundation of quantitative proteomics. This approach has been superseded by isobaric mass tags, which are also used for single-cell protein analysis.
=== 2021–2025 === In his September 2021 speech to the United Nations General Assembly, US president Joe Biden said that the US is "not seeking a new Cold War or a world divided into rigid blocs". Biden further said that the US would cooperate "with any nation that steps up and pursues peaceful resolution to shared challenges", despite "intense disagreement in other areas, because we'll all suffer the consequences of our failure". In May 2022, David Panuelo, President of Micronesia, used the term to state his opposition to a proposed cooperation agreement between China and ten island nations, by claiming it could create a "new 'cold war' between China and the West". In June 2022, journalist Michael Hirsh used the term "Global Cold War" to refer to tensions between leaders of NATO (North Atlantic Treaty Organization) and China and its ally Russia, both countries striving to challenge the US's role as a superpower. Hirsh further cited growing tensions between the US and China as one of the causes of the newer Cold War alongside NATO's speech about China's "systemic challenges to the rules-based international order and to areas relevant to alliance security". He further cited the Russian invasion of Ukraine in 2022 as one of factors of the newer Cold War's rise. In July 2022, James Traub used the term while discussing how the ideas of the Non-Aligned Movement, a forum of neutral countries organised during the original Cold War, can be used to understand the reaction of democratic countries in the developing world to current tensions.
Sources: en.wikipedia.org
Hong Kong is a special administrative region of China, with executive, legislative, and judicial powers devolved from the national government. The Sino-British Joint Declaration provided for economic and administrative continuity through the handover, resulting in an executive-led governing system largely inherited from the territory's history as a British colony. Under these terms and the "one country, two systems" principle, the Basic Law of Hong Kong is the regional constitution. The regional government is composed of three branches:
== Treatment == Since the presentation and course of disease differ greatly from patient to patient, treatment must take into account the degree of involvement, the existence of systemic versus arthritic characteristics, and the presence or absence of MAS. Often, nonsteroidal anti-inflammatory medications can be administered safely to offer analgesic and antipyretic effects without changing the results of the first diagnostic assessment. Clinical trials have shown that anti-interleukin-6 drugs, such as tocilizumab, and anti-interleukin-1 medications, such as anakinra, canakinumab, or rilonacept, are highly successful in managing the disease's systemic symptoms.
The engineer David Speyrer said this was wrong in hindsight and that Valve could have completed it in two years. Newell felt completing Episode Three just to continue the story would have been a "copout", and said: "The failure, my personal failure, was being stumped. I couldn't figure out why doing Episode Three was pushing anything forward."
Sources: en.wikipedia.org
== Awards and honors == Okan won the Publication Incentive Award for his work. In addition to his election to the fellowship of the Royal Colleges of Physicians of Edinburgh, Ireland and London; his memberships include the Turkish Society of Dermatology, American Society of Dermatology, Health Volunteers Overseas, and European Academy of Dermatology and Venereology.
==== Isoenzymes ==== Isoenzymes, or isozymes, are multiple forms of an enzyme, with slightly different protein sequence and closely similar but usually not identical functions. They are either products of different genes, or else different products of alternative splicing. They may either be produced in different organs or cell types to perform the same function, or several isoenzymes may be produced in the same cell type under differential regulation to suit the needs of changing development or environment. LDH (lactate dehydrogenase) has multiple isozymes, while fetal hemoglobin is an example of a developmentally regulated isoform of a non-enzymatic protein. The relative levels of isoenzymes in blood can be used to diagnose problems in the organ of secretion .
== Biosynthesis == The formation of mature elastic fibers, known as elastogenesis, requires the coordinated production and assembly of tropoelastin with a fibrillin-rich microfibrillar scaffold. Tropoelastin is secreted by elastogenic cells, including fibroblasts and vascular smooth-muscle cells, and undergoes coacervation before being deposited onto microfibrils. Proteins including fibulin-4, fibulin-5, and latent transforming growth factor beta-binding protein 4 participate in the organization and stabilization of the developing elastic-fiber matrix.
Sources: en.wikipedia.org
Sealed, protected from light, and refrigerated at two to eight degrees Celsius for most research material. Desiccated storage limits moisture uptake. Allow the vial to reach room temperature before opening to prevent condensation.
Each cycle exposes the peptide to ice-liquid interfaces where unfolding and aggregation can occur. Aggregates may not redissolve and can alter measured activity. Aliquoting before the first freeze reduces the number of cycles any single portion experiences.
It usually reports purity by HPLC, identity by mass spectrometry, peptide content, appearance, and residual moisture or counterion content. The analytical method behind each value should be stated. Acceptance criteria are set by the supplier or the buyer's specification.
It is a synthetic analog of GLP-1 produced through medicinal chemistry to resist enzymatic degradation. The design goal was longer circulation than the native hormone.